Congenital Hematological Disorder Completed Phase 2 Trials for Eptacog alfa pegol (activated) (DB11661)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00951405Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With InhibitorsPrevention